BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9039291)

  • 1. Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas.
    Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
    Br J Dermatol; 1997 Jan; 136(1):30-4. PubMed ID: 9039291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas.
    Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
    APMIS; 1997 Jan; 105(1):35-40. PubMed ID: 9063499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.
    Haerslev T; Rossen K; Hou-Jensen K; Jacobsen GK
    Acta Derm Venereol; 1995 May; 75(3):187-9. PubMed ID: 7653177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization.
    Han KH; Huh CH; Cho KH
    Am J Dermatopathol; 2001 Apr; 23(2):90-8. PubMed ID: 11285402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas.
    Goette DK; Helwig EB
    Arch Dermatol; 1975 May; 111(5):589-92. PubMed ID: 165782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
    Lindboe CF; Løvdal L
    Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
    Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
    J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
    Stashower ME; Smith K; Corbett D; Skelton HG
    J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
    Rossen K; Hou-Jensen K; Werdelin O
    Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of metallothionein in endometrial lesions.
    Ioachim EE; Kitsiou E; Carassavoglou C; Stefanaki S; Agnantis NJ
    J Pathol; 2000 Jul; 191(3):269-73. PubMed ID: 10878548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal basaloid proliferation in cutaneous myxomas.
    Mehregan DR; Thomas L; Thomas JE
    J Cutan Pathol; 2003 Sep; 30(8):499-503. PubMed ID: 12950501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maspin expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
    Werynska B; Pula B; Muszczynska-Bernhard B; Piotrowska A; Jethon A; Podhorska-Okolow M; Dziegiel P; Jankowska R
    Anticancer Res; 2011 Sep; 31(9):2833-9. PubMed ID: 21868526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.
    Morgan J; Oseroff AR; Cheney RT
    Br J Dermatol; 2004 Oct; 151(4):846-56. PubMed ID: 15491426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
    J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic characterization of human keratinocytes in coculture reveals differential effects of fibroblasts from benign fibrous histiocytoma (dermatofibroma) as compared to cells from its malignant form and to normal fibroblasts.
    Kideryová L; Lacina L; Dvoránková B; Stork J; Cada Z; Szabo P; André S; Kaltner H; Gabius HJ; Smetana K
    J Dermatol Sci; 2009 Jul; 55(1):18-26. PubMed ID: 19414239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
    Tan Y; Sinniah R; Bay BH; Singh G
    J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.